Sickle cell disease birth prevalence examined in newborns from high social vulnerability counties

This observational report examined the birth prevalence of sickle cell disease among newborns born to mothers residing in counties with high social vulnerability. The analysis was conducted across 11 states, though the specific sample size, intervention or exposure, comparator groups, and follow-up duration were not reported. The study did not provide primary or secondary outcome data, effect sizes, absolute numbers, or statistical measures for sickle cell disease prevalence.

No safety or tolerability data were reported, as this was a prevalence surveillance report rather than an interventional study. The report did not document adverse events, serious adverse events, or discontinuations related to the condition.

Key limitations include the absence of reported prevalence data, results, and methodological details such as sample size and specific outcome measures. The funding sources and potential conflicts of interest were also not reported. The practice relevance of this report is limited to highlighting a surveillance gap rather than providing clinically actionable prevalence estimates for sickle cell disease in this vulnerable population.